156 related articles for article (PubMed ID: 18781149)
21. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin dosing for adult Japanese patients.
Ando Y; Shimokata T; Yasuda Y; Hasegawa Y
Nagoya J Med Sci; 2014 Feb; 76(1-2):1-9. PubMed ID: 25129986
[TBL] [Abstract][Full Text] [Related]
23. Estimation of glomerular filtration rate in cancer patients.
Wright JG; Boddy AV; Highley M; Fenwick J; McGill A; Calvert AH
Br J Cancer; 2001 Feb; 84(4):452-9. PubMed ID: 11207037
[TBL] [Abstract][Full Text] [Related]
24. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
Morrow A; Garland C; Yang F; De Luna M; Herrington JD
J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
[TBL] [Abstract][Full Text] [Related]
25. Nephrotoxicity following carboplatin use in children: is routine monitoring of renal function necessary?
Brandt LJ; Broadbent V
Med Pediatr Oncol; 1993; 21(1):31-5. PubMed ID: 8426573
[TBL] [Abstract][Full Text] [Related]
26. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
Warren K; Gervais A; Aikin A; Egorin M; Balis FM
Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
[TBL] [Abstract][Full Text] [Related]
28. Plasma clearance rate of 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans.
Sambataro M; Thomaseth K; Pacini G; Robaudo C; Carraro A; Bruseghin M; Brocco E; Abaterusso C; DeFerrari G; Fioretto P; Maioli M; Tonolo GC; Crepaldi G; Nosadini R
J Am Soc Nephrol; 1996 Jan; 7(1):118-27. PubMed ID: 8808118
[TBL] [Abstract][Full Text] [Related]
29. Extension of the Calvert formula to patients with severe renal insufficiency.
Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
[TBL] [Abstract][Full Text] [Related]
30. Estimating GFR in children with 99mTc-DTPA renography: a comparison with single-sample 51Cr-EDTA clearance.
Gutte H; Møller ML; Pfeifer AK; Thorup J; Borgwardt L; Borgwardt L; Kristoffersen US; Kjaer A
Clin Physiol Funct Imaging; 2010 May; 30(3):169-74. PubMed ID: 20214666
[TBL] [Abstract][Full Text] [Related]
31. Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.
Peng B; Boddy AV; Cole M; Pearson AD; Chatelut E; Rubie H; Newell DR
Eur J Cancer; 1995 Oct; 31A(11):1804-10. PubMed ID: 8541105
[TBL] [Abstract][Full Text] [Related]
32. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
[TBL] [Abstract][Full Text] [Related]
33. New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.
Janowitz T; Williams EH; Marshall A; Ainsworth N; Thomas PB; Sammut SJ; Shepherd S; White J; Mark PB; Lynch AG; Jodrell DI; Tavaré S; Earl H
J Clin Oncol; 2017 Aug; 35(24):2798-2805. PubMed ID: 28686534
[TBL] [Abstract][Full Text] [Related]
34. Indexing glomerular filtration rate to suit children.
Bird NJ; Henderson BL; Lui D; Ballinger JR; Peters AM
J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
[TBL] [Abstract][Full Text] [Related]
35. Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault.
Tsang C; Akbari A; Frechette D; Brown PA
J Oncol Pharm Pract; 2021 Mar; 27(2):368-375. PubMed ID: 33297846
[TBL] [Abstract][Full Text] [Related]
36. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
Samani A; Bennett R; Eremeishvili K; Kalofonou F; Whear S; Montes A; Kristeleit R; Krell J; McNeish I; Ghosh S; Tookman L
ESMO Open; 2022 Apr; 7(2):100401. PubMed ID: 35227967
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy.
Veal GJ; English MW; Grundy RG; Shakespeare C; Glaser A; Waters F; Holden V; O'Meara A; Michalski A; Howe K; Cole S; Boddy AV
Cancer Chemother Pharmacol; 2004 Oct; 54(4):295-300. PubMed ID: 15133627
[TBL] [Abstract][Full Text] [Related]
38. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics and dose optimisation of carboplatin.
Duffull SB; Robinson BA
Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
[TBL] [Abstract][Full Text] [Related]
40. Dose-banding of carboplatin: rationale and proposed banding scheme.
Kaestner S; Sewell G
J Oncol Pharm Pract; 2007 Jun; 13(2):109-17. PubMed ID: 17873111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
